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ABSTRACT 
IDENTIFICATION AND CHARACTERIZATION OF MSAB GENE INVOLVED IN 
BIOFILM FORMATION AND VIRULENCE IN STAPHYLOCOCCUS AUREUS 
by Amelsaad Elbarasi 
August 2014 
 Staphylococcus aureus is an important human pathogen that causes a wide 
variety of life-threatening infections ranging from minor skin and oral infections to 
severe infections, such as bacteremia, pneumonia, osteomyelitis, or endocarditis due to 
the presence and secretion of a large number of virulence factors that are controlled by 
global virulence regulators in complex networks. Furthermore, S. aureus infections have 
become a threat to public health because of their high potential to form biofilm, and their 
ability to resist a wide range of antibiotics has exacerbated further. Therefore, 
understanding the regulatory networks and developing a drug targeting these networks 
has the potential to stand as therapeutic targets for future treatment of antibiotic resistant 
infections. 
In a previous study msaC was identified as the modulator of sarA, a new global 
virulence regulator that controls the expression of sarA and biofilm development. 
Furthermore, it has also been shown that msaC is a part of four-gene operon, msaABCR 
operon, which includes four-genes: SAUSA300_1296 (msaA), SAUSA300_1295 (msaB), 
SAUSA300_1294 (msaC), and antisense RNA, msaR. The mechanism of regulation of 
msaABCR operon and the function of individual genes were not clearly known yet. This 
study defines the role of msaB, the second gene of the msaABCR operon, which will help 
shed some light on the regulation of msaABCR. We deleted msaB gene from 
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USA300_LAC, and studied the major msaB phenotypes: pigmentation, protease 
production, biofilm formation, and rate of cell death. Deletion of msaB resulted in the 
similar msaC and/or msaABCR deletion mutant, thus showing the importance of this gene 
in this operon. The mutant showed decreased pigmentation, increased extracellular 
protease production, decreased biofilm formation, and increased rate of cell death. 
Deletion of the msaB gene also resulted in the decreased expression of some key 
regulators, like sarA and agr that play major roles in the regulation of virulence and 
biofilm formation in S. aureus, similar to msaC and msaABCR operon deletion mutant. 
Thus, this study identifies the role of msaB, in the msaABCR operon, that will 
help us define the mechanism of regulation of virulence and biofilm formation by the 
msaABCR operon and provides a step to investigate the stimulatory signals that the 
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Staphylococcus was first identified in 1880 in Aberdeen, United Kingdom, by the 
surgeon Sir Alexander Ogston in pus from a surgical abscess in a knee joint, and this 
name was later appended to staphylococcus aureus (S. aureus) by Rosenbach, who was 
credited by the official system of nomenclature at that time. S. aureus is an anaerobic 
facultative gram-positive bacterium; it is a member of the Firmicutes, and it’s also known 
as golden staph due to its ability to produce a carotenoid pigmentation as is shown in 
Figure 1. S. aureus is positive for catalase and nitrate reduction, and this feature 
differentiates it from other micrococcaceae like streptococci, and enterococci. It is 
estimated that 20% of the human population is a long-term carrier of S. aureus [1] which 
can be found as part of the normal skin flora, anterior nares, throat, axilla, perirectal area,  
and groin area [1, 2].  
 
Figure 1. Staphylococcus aureus has been grown on TSA (Tryptic Soy Agar) media. The 









Although S. aureus is not always pathogenic, it may cause a wide variety of life-
threatening infections when it enters in the human body; its ability to acquire resistance to 
antibiotics very rapidly and its ability to form biofilm to cause biofilm-associated 
infection is very alarming. S. aureus is an important human pathogen associated with one 
of the most common cause of healthcare and community-associated infections [3]. Even 
though, it has been over 100 years since the discovery of S. aureus, the mode of action is 
still controversial and it has to be fully elucidated.  Since human are considered a natural 
reservoir of S. aureus, it is estimated that around 30 to 50 percent of the human 
population is persistently colonized with both methicillin-sensitive and methicillin-
resistant isolates [4, 5].  
The frequencies of both community-acquired and hospital-acquired 
staphylococcal infections have increased steadily over the past 20 years, with little 
change in overall mortality [6], and during the period from 1990 through 1992, S. aureus 
was the most common causes of nosocomial infection according to data from the 
National Nosocomial Infections Surveillance system of the Centers for Disease Control 
and Prevention (CDC), and they spread rapidly to populate many hospitals and diverse 
geographic regions with unique processes and yet undefined pathogenicity [7, 8].  
Impact of S. aureus on Oral Cavity 
The oral cavity acts as a reservoir for many pathogens that may cause local or 
systemic infections [9]; for instance, saliva and the periodontal pocket serve as an 
ecological niche appropriate for hosting microorganisms that could act as opportunistic 
pathogens. There are over 700 different bacterial species in the oral microflora [10], and 




palate, tongue, teeth, carious lesions, and periodontal pocket. The distribution of 
microflora in the oral cavity is not random, most species prefer certain sites over others 
due to the particular local environment those sites provide [11]. Cuesta Al et al. 2010 [12] 
showed that the oral cavity and sub-gingival pocket are ecological niches for 
microorganisms that may act as opportunistic pathogens, such as S. aureus and especially 
methicillin-resistant S. aureus (MRSA) is one of them. Early detection of MRSA is a 
matter of concern to Public Health that can help prevent further infections. 
 Passariello et al. 2012 [13] also found that the oral cavity is an important site of 
S. aureus colonization and showed that conditions modifying the oral environment, such 
as the presence of periodontitis and fixed prosthetic restorations, promote S. aureus and 
may favor the spread of more pathogenic strains. Information regarding the risk of 
methicillin-resistant Staphylococcus aureus (MRSA) infection transmission in dental 
healthcare settings was incomplete only a few years ago; therefore, MRSA infection 
control guidelines were necessarily based on data extrapolated from other fields. Recent 
publications have made it possible to review such risk. The relationship among these 
pathogens, periodontal bacteria, and periodontal clinical status is poorly understood. 
 S. aureus colonizes and causes infection of the oral cavity and this is an 
important aspect in its pathogenesis because it has been isolated from a wide  variety of 
oral infective conditions, as angular parotitis and cheilitis [14]. Recently, staphylococcal 
infection has been shown in a clinical condition, which classified as staphylococcal 
mucositis, emerging as a clinical problem in many debilitated old patients and those 
suffering from oral Crohn's disease [15]. Also, higher caries rates of Coagulase negative 




joint infections, which raises the possibility of the oral cavity serving as a potential 
source for spread of bacteremia to compromised joint spaces [16].   
Furthermore, Staphylococci isolated from sub-gingival samples of patients with 
advanced periodontitis were tested for leukocidal activity. Intact organisms, bacterial 
sonicator, or bacterial culture supernatants were incubated with human neutrophils that 
had been pre-labeled with 51chromium. The most common of S. aureus periodontal 
isolates provoked dose-dependent extracellular release of the radiolabel. By contrast, 
other strains of staphylococci had marginal or no demonstrable leukocidal activity. 
Leukocidal activity was heat-sensitive and was neutralized by horse anti-leukocidin 
antibodies. The results indicate that S. aureus colonizing human periodontal lesions 
elaborate a leukocidin that may conceivably destroy neutrophils that immigrate into the 
gingival region. This could adversely affect the overall status of this antimicrobial 
defense system in the gingival area and contribute to the pathogenicity of S. aureus as 
well as other potential periodontopathic organisms [17].  
Biofilms in the Oral Cavity 
Accumulation of bacterial biofilm (plaques) on tooth surfaces results in some of 
the most prevalent bacterial-induced diseases of man—caries and inflammatory 
periodontal diseases [18]. The former is due to the accumulation of the biofilm 
supragingivally and involves dissolution of enamel and dentine. The latter stem from a 
build-up of plaque at and below the gingival margin and the irreversible phase of the 
disease, chronic periodontitis, that is characterized by detachment of the gingiva from the 
root surface of the tooth, resulting in a periodontal pocket and, ultimately, resorption of 




to solve the puzzle of staphylococci pathogenesis in the oral cavity but it still remains 
unclear and requires more research in this area. 
The S. aureus Virulence and Biofilm Development 
The ability of S. aureus to infect a variety of tissues in the human body is due to 
its expression of a wide variety of virulence factors such as surface-associated proteins, 
secreted proteases, toxins, and immune modulators [19]. Expression of these virulence 
factors in is carefully coordinated by a variety of regulators that include trans-acting 
global regulators, alternative sigma factors, and small non-coding RNAs [20]. The 
community-acquired methicillin-resistant S. aureus (CA-MRSA) strains often cause 
localized infections by producing various enzymes, such as protease, lipase, and 
hyaluronidase, that destroy the tissues in immune-compromised hosts. These strains show 
enhanced virulence leading to severe infections among healthy individuals without any 
predisposing risk factors; however, their role in the pathogenesis of disease is still not 
well understood.  
 One of the major factors responsible for the establishment of chronic infection by 
S. aureus is its ability to form biofilm virtually on any host surfaces [21]. S. aureus can 
form biofilms on host surfaces like heart valves, bone [22], cartilage, and medical 
implants like catheters and orthopedic devices [23, 24].  
A biofilm is an aggregation of any group of microorganisms, in which the cells 
stick to each other and upon a solid surface, typically with a fluid of microbes bathing 
[25]. Biofilms can be found everywhere on living or non-living surfaces and can be 
prevalent in natural, industrial, and hospital settings. The main components of mature 




These adherent cells are frequently embedded within a self-produced matrix of 
extracellular polymeric substance (EPS). Biofilm EPS, which is also referred to as slime 
(although not everything described as slime is a biofilm), is a polymeric conglomeration 
generally composed of extracellular DNA, polysaccharide and proteins. These microbial 
communities form micro-colonies that interact with each other using very sophisticated 
communication methods (i.e., quorum-sensing) [27]. The development of unique 
microbiological tools to detect and assess the various biofilms around us is a 
tremendously important focus of research in many laboratories. 
The S. aureus biofilm forms in three distinct stages as shown in Figure 2: 
1.  The free-floating cells attach to the surfaces by means of adhesions or cell wall 
components, which also help other microorganisms to attach to the surface because they 
cannot do it on their own.  
2.  Accumulation of the multilayered cells via subdivision, and then they start production 
of their self-polysaccharide matrix, which help maturation of the biofilm. 
3.  Detachment of biofilm cells and dispersal to new distant sites for colonization or to 






Figure 2. Schematic represents stages of biofilm formation. 
This fully matured stage is characterized by an overall shift in gene expression 
patterns total different from the planktonic stages and offering increased resistance to 
antimicrobials. Once they are fully developed biofilm, via production of some biofilm 
destabilizing proteins like phenol soluble modulins (psms), disassembly of biofilm occurs 
resulting in free-floating planktonic cells (dispersion) that are able to re-initiate the 
biofilm development process in another site [28]. Several factors like extracellular 
matrix, reduced metabolic state of bacteria within the biofilm, and efficient spread of 
antibiotic resistance mechanisms via gene transfer within the biofilm community 
contribute to the biofilm recalcitrance [29].  
Global Regulators in S. aureus 
The S. aureus genome has 124 putative transcriptional regulators [30], and several 
global regulators have been identified, which include the agrA operon, the sarA gene 
family, the saePQRS operon, and the genes arlRS, lytSR, srrAb, hssRS, vraSR, and graSR 
[31, 32]. Several other regulators have also been identified, though they are not as well 




The first and most important globular regulator gene in S. aureus genome is 
Staphylococcal accessory regulator A (SarA); its family of homologs is transcriptional 
regulators that control the expression of several genes [34], including virulence factors, 
and biofilm formation. The sarA locus comprises three promoters (P1, P2, and P3) that 
drive expression of three transcripts, sarB, sarC, and sarA, respectively; however, the 
mechanism of regulation of sarA is not fully understood [35]. Indeed, the environmental 
signals that modulate the expression of SarA or its activity are not known either. 
Inactivation of sarA leads to a reduction in biofilm formation [36], and it is epistatic to 
agr (accessory gene regulator ) during biofilm formation [37, 38]. SarA mutants are 
deficient in biofilm formation and show reduced expression of the icaADBC operon, 
increased protease and nuclease activity, and degradation of surface-associated proteins 
like FnbA, FnbB, and spa [36, 39, 40]. 
The next globular regulator, accessory gene regulator (agr) is also a global 
regulator that encodes a quorum-sensing system in S. aureus, and the main effector 
molecule of agr is RNAIII, which is expressed in temporal fashion, reaching a maximum 
in the transition from the post-exponential to the stationary growth phase. Repression of 
agr is also important for biofilm formation [41].  
The agr system regulates a large number of virulence factors, especially 
exoprotein genes like hla, hlb, hld, hlCB, sspABC, splABDF, aur, and many others, 
whereas it decreases the expression of several cell wall-associated protein genes like 
fnbA, fnbB, spa, and coa [42]. 
The other important global regulator is the alternate sigma factor B (sigB), which 




regulates its targets via other regulatory genes or by acting directly on the promoters of 
virulence genes. Although sigB positively regulates expression of sarC and negatively 
regulates agr, its effect on sarA is not yet known [45, 46]. It seems that sigB acts in 
opposition to RNAIII, as most of the exoenzymes and toxins were negatively influenced 
by sigB, while the expression of several adhesions was increased [47]. 
We recently identified a new global regulator named msaABCR operon, 
modulator sarA that plays a role in autolysis, biofilm formation, and virulence in the 
clinical isolate of community acquired S. aureus strain USA300_LAC [48].  In addition,  
it also regulates the expression of some other well studied global regulators including 
sarA, agr, and sigB, which plays a role in pathogenesis. So understanding virulence 
regulation during growth under different environmental conditions (e.g., biofilm 
development) is imperative for the effective prevention and treatment of S. aureus 
infections.  
In this study, we deleted the second gene of msaABCR operon, msaB gene, by an 
allelic gene replacement method and studied the phenotypes of msaB gene and compared 
with the msaC and msaABCR deletion mutant in order to elucidate the role of this gene in 
the operon.  
Although it was not clear if msaB gene regulated virulence genes directly via its 
effect on global regulators (SarA and agr genes) or if it has a different pathway, we did 
not discover it yet in this experiment. Since sarA has been shown to be essential for 
biofilm development in several strains [36], it is not clear if the msaB defect is due to the 





Sequence analysis of the msaB gene showed it is conserved among S. aureus 
strains and encodes a protein that is a cold shock domain, which is a member of a family 
of small cold-shock proteins (CSPs) that are induced during bacterial cell response to 
stress like low temperatures. Bioinformatics analysis also showed that this protein 
preferentially binds single-strand RNA and DNA and appears to play an important role in 
cell physiology under both normal and cold-shock conditions. Although, the function of 
CSPs in cold-shock adaption has not yet been elucidated in detail, a number of 
experimental evidence suggests that CSPs bind messenger RNA (mRNA) and regulates 
ribosomal translation, the rate of m-RNA degradation, and the termination of 
transcription [49]. Interestingly, the cold shock protein family has shown structural 
similarity in different bacterial species (for instance, E.coli, Mycobacterium tuberculosis, 
Streptococcus pyogenes, Pseudomonas aeruginosa, Yersinia pestis, and Haemophilus 
influenzae) and in other important species such as human, Caldosporium herbarum, and 
C.elegans [50]. 
The Goals of This Project 
Our previous study showed that msaABCR is an operon that contains three non-
coding RNAs, msaA, msaC, and msaR, and it interacts with other global regulators like 
sarA, agr, and sigB; however, the mechanism of regulation and role of each gene in the 
operon has been studied. In this study we elucidate the role of msaB in the msaABCR 





CHARACTERIZATION OF MSAB GENE 
Abstract 
 Staphylococcus aureus is an important human pathogen that causes a wide variety 
of infections because S. aureus produces a vast array of virulence factors that are 
controlled by global virulence regulators. Previously identified msaABCR is a new global 
virulence regulator that controls the expression of sarA, agr, and sigB and virulence and 
biofilm development in S. aureus [48].. To define the role of individual genes in the 
operon, we deleted msaB gene from USA300_LAC strain and compared its phenotype to 
single msaC mutant and msaABCDR operon deletion mutant. 
 Our preliminary data showed that the studied phenotypes of msaB deletion 
mutants are similar to both msaC and msaABCDR operon deletion mutants, and showed 
decreased pigmentation, increased extracellular protease activity, increased cell death, 
and reduced biofilm formation. The whole msaABCR operon gene is required for the full 
complementation of msaB gene, which also supports our previous findings that all genes 
in an operon in cis are required for the function of this operon. Defining the mechanism 
of action of the msaABCDR operon locus, its role in virulence and biofilm development 
will build more information for understanding S. aureus network virulence in order to 
combat their outbreak in the near future.  
Introduction 
The S. aureus causes life-threatening infections because it produces large 
numbers of virulence factors and posses complex regulatory networks that control these 




its ability to resist a wide range of antibiotics. Therefore, understanding the function of 
complex regulatory networks that regulate the virulence factors and pathogenicity of S. 
aureus is important to develop potential future therapeutic targets against these 
pathogens, which are very inflexible against antibiotic treatment [52]. Some of the 
important global regulators of virulence in S. aureus are msaABCR, sarA, sigB, and agr. 
We have previously shown that msaABCR operon positively regulates the expression of 
some global regulators like sarA, agr, and sigB, which they are very well studied global 
regulators that globally regulate virulence and biofilm development in S. aureus. In this 
study, we studied the role the second gene of msaABCR operon, msaB gene, in order to 
elucidate the role of this gene in the operon.  
Materials and Methods 
The Bacterial Strains and Plasmids  
All strains and plasmids used in this study are listed in Table 1 below. The S. 
aureus strains (community-acquired MRSA strain USA300_LAC, restriction-deficient 
laboratory strain RN4220), E. coli strain DH5α, pJB38 gram positive shuttle vector, and 
pCN34 low copy plasmid vector were used in this study. The S. aureus strains were 
grown in tryptic soy broth (TSB) medium. Antibiotics (chloramphenicol (10 µg/ml), 
erythromycin (10 µg/ml), and kanamycin (50 µg/ml) were used in TSB or TSA where 
needed. Similarly, E. coli strains were grown in LB broth with ampicillin (100 µg/ml) 
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 Bacteria Strains and Plasmids Used in This Study 
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Table 1 (continued). 
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Construction of msaB Deletion Mutant and its Complementation 
The upstream and downstream flanking regions of msaB gene were amplified by 
using high fidelity PCR reaction using primers MsaB_upstr_F/R and MsaB_dnstr_F/R 
respectively (All primers used in this study are listed in Table 2 below). The upstream 
and down-stream PCR products were digested with bamHI and ligated to amplify the 
ligated PCR product using the terminal primers MsaB_upstr_F and MsaB_dnstr_R. The 
amplified ligated PCR product and pJB38 plasmid vectors were again digested with knpI 
and salI, purified, and then ligated to construct the deletion plasmid construct 




sensitive shuttle vector was used to successfully delete other S. aureus genes; one of the 
special features of pJB38 is that it offers an inducible counter selection with 
anhyrotetracycline (aTc) that selects for chromosomal excision and loss of plasmid 
without the use of an antibiotic.  The pJB38_msaB deletion plasmid construct was 
transduced in wild type S. aureus strain USA300_LAC, and deletion procedures were 
followed as described in Sahukhal and Elasri, 2014 [48]. 
The msaB complement was constructed by amplifying the wild type msaB gene 
from wild type LAC strains with complmsaB F/R primers, that contain restriction site 
BamHI and EcoRI, respectively. The amplified msaB gene and gram-positive low copy 
number shuttle vector, pCN34, was digested with BamHI and EcoRI, and ligated with the 
amplified msaB gene. The pCN34 vector containing msaB gene (pCN34-msaB) was then 
inserted into RN4220 by electro-transformation. The transformants containing pCN34-
msaB were confirmed by restriction digestion and sequencing. Finally, pCN34-msaB 
gene was transduced into an msaB deletion construct and was used as the complement 
strain for the study. 
Table 2  
The Primers Used in This Study 
 
       Primer for msaB deletion and msaB complement 
 










Table 2 (continued).   
 
MsaB dnstr F 
 
MsaB dnstr R 
 
MsaB compl F             
 















   
RNA Isolation and Real-Time qPCR 
The total RNA was harvested and the Real-time PCR was performed as 
previously described in Sahukhal and Elasri, 2014 [48]. In brief, overnight cultures of S. 
aureus were diluted to an OD600 of 0.05 in TSB and incubated at 37°C with shaking (200 
rpm) until they reached an OD600 of 4.0, and RNA was harvested using RNeasy mini kit. 
The quality of the total RNA was determined by Nano-drop and a Bioanalyzer (Agilent), 
and Real time PCR was performed. The constitutively expressed gyrase A (gyrA) gene 
has been used as an endogenous control gene and has been included in all experiments.  
Analysis of expression of each gene has been done based on at least three 
individual experiments, and two-fold or higher changes in gene expression have been 









Table 3  
Primers Used in RT-qPCR 
Phenotypic Assays 
1.  Triton X-100 induced autolysis. Autolysis assay was performed using Triton 
X-100 as described by Manna et al. 1997 [53]. Overnight bacterial cultures were diluted 
to an OD 600 of 0.05 in TSB broth contain 1M NaCl.  The bacteria were grown until the 
optical density A580 0.7. The cells were collected by centrifuging at 10,000 rpm for 10 
min at 4˚C, and then the cells were washed twice with ice-cold autoclaved water and then 
were suspended in autolysis buffer (50 mM Tris-HCl (pH 7.5) containing 0.1% (v/v) 
Triton-x-100). The rate of autolysis was measured at A580 every 30 min intervals for 3 
hrs.  
 
        Primers used in RT-qPCR analysis 
 
 
RT msaB F 
 
TTTATCGAAGTTGAAGGAGAAAATG 
RT msaB R ACTCAACAGCTTGACCTTCTTCTAA 
RT sarA F 
RT sarA R 
TTTGCTTCAGTGATTCGTTTATTTACTC 
GTAATGAGCATGATGAAAGAACTGTATT 
RT agrA F TTTGTCGTCAATCGCCATAA 
RT agrA R 
RT gyrA F 








2.  Pigmentation assay. A pigmentation assay was performed on cells harvested 
from overnight cultures, as described by Morikawa et al. 2001 [54]. Briefly, 1 ml of the 
over-nightly grown cells were harvested and washed twice with water. They were then 
suspended in 1 ml of methanol and heated at 55°C for 3–5 min with occasional vortexing. 
The cells were removed by centrifugation at 15,000-x g for 1 min, and the absorbance of 
the supernatant was measured at 465 nm with water as a blank. Mean values from a 
minimum of three independent experiments, each performed in triplicate, were recorded.  
3.  Protease assay. Protease activity assay was performed as described by 
Sambanthamoorthy et al. 2006 [55].  In brief, 300 µl of the culture supernatant from 
overnight cultures were mixed with 800 µl of 3 mg azocasein ml−1 in Tris-buffered saline 
(pH 7.5) and incubated overnight at 37°C in dark. After incubation un-degraded 
azocasein was precipitated by adding 400 µl of 50% (w/v) trichloroacetic acid, removed 
by centrifugation, and the amount of acid-soluble azocasein was determined by 
measuring at 340 nm using water as blank. We took the mean values from a minimum of 
three independent experiments, each performed in triplicate, and recorded.  
4.  Microtiter plate Biofilm assay. The microtiter biofilm assay was performed as 
described in Sambanthamoorthy et al. 2008 [56] but with slight modification. Briefly, 
overnight cultures of cells, including wild type, mutant, and the complemented strain of 
USA300 LAC were diluted 1:100 times in TSB supplemented with 3% NaCl and 0.25% 
glucose and inoculated in microtiter plates pre-coated with 20% human plasma. Cultures 
were incubated for 24 or 48 hrs with shaking at 150 rpm. The adherent biofilm was 
quantitated at 615 nm after washing and staining with crystal violet and elution with 5% 




microplate spectrophotometer system. Experiments were performed in triplicate and three 
independent experiments were performed for each of this assay. 
Confocal Microscopy of Biofilm 
For confocal microscopy assay of biofilm produced by the msaB deletion mutant, 
the biofilms were grown on microtiter as described above. The 48 hrs biofilm was stained 
with live-dead cell stains Syto-9 [1.3 µm] and Toto-3 [2.0 µm] respectively. The stains 
were prepared in 2 ml of filter-sterilized PBS buffer prior to be used for staining.  The Z-
stack images of the biofilm were taken under 60X objective with oil immersion. The 
Syto-9-dye (Green fluorescence) was excited with an argon laser at 488 nm, and the 
emission band-pass filter used for Syto-9 was 515 ± 15 nm, and was used to stain the live 
cells in the biofilm. The Toto-3-dye (Red fluorescence) was excited using a HeNe 633-
nm laser, and emissions were detected using a 680 ± 30-nm filter, and was using to stain 
the dead cells and eDNA, then incubated at 30oC in dark for 10 minutes. The images 
obtained by CLSM were analyzed using the COMSTAT program where the total biomass 
of the biofilms, thickness of the biofilm, and amount of live and dead cells within the 
biofilm were quantified. 
Effect of Different Environmental Conditions on Static Biofilm Formation by msaB 
Mutant 
To study the effect of different environmental conditions that affect biofilm, the 
static microtiter biofilm was grown as described above, but in the presence of different 
concentrations of NaCl, glucose, and ethanol tested. To test the different concentrations 
of NaCl, the TSB with 0.5% glucose concentration supplemented with sodium chloride at 




To test the different concentrations of glucose, the TSB with 3% NaCl 
supplemented with glucose at concentrations ranging from 0 to 5% was used. Similarly, 
to test the effect of different concentrations of ethanol, TSB with 3% NaCl, supplemented 
with ethanol at concentrations 0.5% to 6%, and TSB with 0.5% Glucose, supplemented 
with ethanol at concentrations 0.5% to 6%, were used. The biofilms were grown in 
presence of different concentrations of NaCl, glucose, and ethanol, as mentioned earlier 
in separate microtiter plate, incubated for 48 hrs, washed three times and quantified as 
described above. 
Biofilm Detachment Assays 
We studied the effect of different chemicals and media that affects the biofilm 
stability. To determine the sensitivity of biofilms to Sodium metaperiodate, DNase I, 
proteinase K, the biofilm was grown in human plasma coated microtiter plate as 
described above for 48 hrs and treated them as previously described in Rice et al. 2007 
[57]. Briefly, the biofilm was grown in biofilm media and incubated at 37°C with shaking 
at 150 rpm each for every chemical tested. Sodium metaperiodate (10mM), DNase I 
(10U/ml), and Proteinase K (100ug/ml) were introduced at different point time intervals 
(0 to 12 hrs) in their respectively labeled plates and further incubated till 48 hrs. After 
incubation, the wells were rinsed gently with 200 ul of PBS three times, air dried, fixed 
with 100 ul of absolute ethanol, and stained with 0.2% crystal violet for 10 min. The 








Construction of msaB Deletion Mutation in CA-MRSA strain USA300_LAC  
We amplified the upstream and downstream flanking region of msaB gene and 
inserted them into a deletion vector pJB38, to construct the deletion plasmid, pJB38-
msaB. Once we transduced the deletion plasmid into wild type LAC strain, we performed 
the deletion steps as described in the Material and Methods section. We screened and 
confirmed the msaB deletion from LAC by using PCR (Figure 3) and sequencing of the 
PCR product. We then introduced msaB gene  (pCN34-msaB) into msaB deletion mutant 
and used it as the complement construct for further study and we verified the msaB 
mutant complement construct by both sequencing of the PCR product and by using 
restriction digestion of two restriction enzymes, which are Bam HI and EcoRI, as show in 
Figure 4.  
 
Figure 3.  Gel electrophoresis shows poly chain reaction (PCR) using terminal primers to 







                                             
Figure 4. Gel electrophoresis shows restriction digestion to verify the presence of msaB 
complement construct in pCN34-msaB complement construct by using two restriction 
enzymes, Bam HI and EcorI. Upper bands refer to pCN34 plasmid (Vector), which size 
around 7 KB, and lower bands refer to msaB complement construct (Insert), which size 
around 1.5 KB. 
 
 
Figure 5. Shows the msaABCR operon map, which include of the msaA, msaB, msaC, 
and msaR genes (short thick grey arrows). Also it shows different alternative forms of the 



























































































Relative Expression of Global Regulators sarA and agr 
We measured the expression of global regulators sarA and agr by RT-qPCR in 
the msaB deletion mutant. We observed decrease in expression of sarA and agr (Table 4), 
similar to msaC and msaABCR operon deletion mutant [48]. 
Table 4 
Relative Expression of the Global Regulator, SarA, and Agr in the MsaB mutant and its 
Complement Relative to Wild Type (USA300_LAC) 
 
 
     Genes                          MsaB deletion mutation                 MsaB complement 
 
     MsaB                                    -16.767                                            -2.23 
 
     SarA                                      -2.14                                             137.18 
 
      Agr                                      -2.29                                                -2.24 
 
Note: The fold change transcription level in various strains relative to wild-type USA300_ LAC, and the values represent the mean 
ratio of three independent experiments.  
Phenotypic Characterization of msaB Deletion Mutant 
We studied several phenotypes in the msaB deletion mutant and compared with its 
wild type and complement. The msaB deletion mutant showed a significant defect in 
biofilm formation, pigmentation, and showed increased protease production, as well as 
increased rate of cell death (Figures 6, 7, 8, & 9). The phenotypes we observed were 
similar to the msaC deletion and msaABCR operon deletion mutant. This supports the 




msaB cloned in the low copy plasmid pCN34 into the deletion mutants led to an 
increased biofilm formation, increased pigmentation, decreased protease, and decreased 
cell autolysis, confirming that all the phenotypic characteristics we saw were due to 
deletion of the msaB gene.  
 
Figure 6. Phenotypic characterization of msaB deletion mutant and msaB mutant 
complement. Comparison of the msaB deletion mutants relative to complement mutant 
and wild type USA300_LAC. Phenotypic assay was done on Triton X-100 induced lytic 
assay. Values represent the average of three independent assays, each of which was done 
in triplicates. Results are reported as the mean ± S.E, and the standardized errors are 





























Figure 7. Phenotypic characterization of msaB deletion mutant and msaB mutant 
complement. Comparison of the msaB deletion mutants relative to complement mutant 
and wild type USA300_LAC. Phenotypic assay was done on pigmentation, and values 
represent the average of three independent assays, which were done in triplicates. Results 
are reported as the mean ± S.E, and the standardized errors are represented as error bars. 
 
 
Figure 8. Phenotypic characterization of msaB deletion mutant and msaB mutant 
complement. Comparison of the msaB deletion mutants relative to complement mutant 
and wild type USA300_LAC. Phenotypic assay was done on extracellular protease 
activity, and values represent the average of three independent assays, which were done 
in triplicates. Results are reported as the mean ± S.E, and the standardized errors are 


















































Figure 9. Phenotypic characterization of msaB deletion mutant and msaB mutant 
complement. Comparison of the msaB deletion mutants relative to complement mutant 
and wild type USA300_LAC. Phenotypic assay was done on biofilm formation, and 
values represent the average of three independent assays, which were done in triplicates. 




Figure 10. Biofilm formation in msaB mutant in microtiter plates. The wild type strain 
LAC (First row), the msaB mutant strain (Second row), and the complement msaB 
mutant strain (Third row) were grown in TSB supplement with 3% NaCl and 0.5% 
glucose, cultures were incubated for 48 hrs in the wells of microtiter plates with pre-
coating with plasma proteins. The violet staining is an indication of biofilm formation in 
























Confocal Microscopy of Biofilm  
We further analyzed the biofilm formation by the msaB deletion mutant by 
confocal microscopy after staining with live/dead staining with syto-9 and toto-3 and 
compared with WT LAC and its complement. We observed that msaB mutant biofilm is 
unable to form mature peculiar tower-like structure (white arrow head) and more 
aggregation of cells death compared to the LAC and complement (Figure 11). This 
suggests that increased cell death might be responsible for the biofilm defect in the msaB 
mutant, while the importance of other factors still needs to be tested. 
 
A.  B.  C.  
 
Figure 11. Confocal microscopy (Z-stack images) of static biofilm on microtiter plate. 
(A) LAC wild type, (B) msaB mutant, and (C) Complement msaB mutant were grown up 
to 48 hours and stained with Syto-8dye stain (staining live cells with green fluorescence 
stain) and Toto-3dye stain (staining dead cells and eDNA with red fluorescence stain). 
They stained under 40X /1.4 Oil DIC objectives, and these images are representative of 














COMSTAT Analysis of Confocal Microscopy of MsaB Deletion Mutant Biofilm 
We performed COMSTAT analysis for the biofilm formation by the msaB 
deletion mutant and compared with the wild type and its complement. The analysis 
showed the presence of significantly less live cell biomass by the mutant, 40% compared 
to 100% by the wild type. The complement produced the cell biomass intermediate 
between the wild type and complement. Moreover, the mutant showed the presence of 
increased cell death (169%) compared to wild type (100%). This analysis suggests that 
increased number of cell death might be responsible for the defective biofilm formation 
by the msaB mutant. Further analysis by the COMSTAT also revealed that the mutant has 
significantly reduced biofilm thickness (12 µm) compared to wild type (24 um). All the 


















Figure 12. COMSTAT analysis of (A) Live cells, which appear as green columns (B), 
Dead cells, which appear as red columns, and (C) Biofilm thickness (appear as blue 



































 Effect of Different Environmental Conditions on msaB Biofilm 
We examined different environmental conditions that effect biofilm formation on 
msaB mutant and compared them with msaB complement and the wild type 
USA300_LAC. We first examined the effects of osmotic stress (NaCl), which was found 
to induce biofilm formation in biofilm positive strains when grown under stress-induced 
conditions [58]. So in order to test whether msaB gene was involved in transduction of 
the osmolarity signal for biofilm formation, we assayed biofilm formation by wild type 
(LAC), msaB and complement msaB in the presence of different NaCl concentrations. 
We found no significant difference in the biofilm formation by the msaB mutant in any of 
the concentration of NaCl tested compared to its wild type and complement (Figure 13). 
Furthermore, we also tested the effect of ethanol in combination with either NaCl or 
Glucose in TSB. As shown in Figure 10, the biofilm produced by the msaB deletion 
mutant is not significantly different when grown in TSB/ethanol (Figure 14 A) and 
TSB/ethanol/NaCl (Figure 14 C); however, interestingly msaB deletion mutant produced 
significantly increased biofilm in TSB/ethanol/glucose (Figure 14 B). We still need 












Figure 13. Effect of different sodium chloride concentration, 0%, 0.5%, 1%, 2%, 3%, 
4%, 5%, 6%, on biofilm development in msaB mutant strains compared with wild type 
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Figure 14. Effect of ethanol on biofilm formation, (A) shows different ethanol 
concentration, (B) shows different ethanol concentration with constant of 0.5% glucose 
concentration, and (C) shows different ethanol concentration with constant of 3% sodium 
chloride concentration, in msaB mutant strain, msaB complement in comparison to the 
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Glucose has been shown to induce the multicellular aggregation step of biofilm 
formation, increases PIA production [59], and thus induces biofilm formation. We 
studied the effect of different glucose concentrations (0 to 4%) in the biofilm formation 
by msaB mutant.  We observed defective biofilm formation by the msaB deletion mutant 
at low concentration of glucose. But as the concentration of glucose increased from 1% 
onwards, msaB restored the biofilm formation back to wild type level. We still need 
further explanation of and research on why msaB biofilm defect is glucose dependent, 
whereas the wild type and complement does not respond much to the change in glucose 
concentration (Figure 15). 
 
Figure 15. Effect of different glucose concentration, 0%, 0.2%, 0.5%, 1%, 2%, 3%, 4%, 
& 5%, on biofilm development in msaB mutant strain (Red column), msaB complement 
(Green column), and LAC wild type (Blue column); the standardized errors are 
represented as error bars. 
 
  Biofilm Detachment Assay Results 
   Sodium-metaperiodate (NaMP) affects the production of Poly-N-acetyl 
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biofilm is disrupted by the addition of NaMP, then it is intracellular adhesion mediated 
PIA-depended biofilm and if the strain is resistant to the added NaMP, then the biofilm 
formation is PNAG independent [60]. We found that the msaB mutant and its wild type 
and complement strains were resistant to NaMP and does not affect the biofilm formation 

















Figure 16. Effect of sodium metaperiodate on biofilm formation in msaB mutant, msaB 
mutant complement, and wild type strains at different NaMP concentrations with 24 hrs 
incubation (A), and at only one concentration of 20uM/ml, with different times intervals; 
at 0 hour, 6 hrs, and 12 hrs (B); the standardized errors are represented as error bars.  
 
Biofilms were exposed to DNase I (2U per well) at 6 hrs, and at 48 hrs of biofilm 
development, the wells were washed and stained with crystal violet and the amount of 
biofilm remaining was quantified at 595 nm. The addition of DNase I reduced the 
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biofilm formation (Figure 17). Since there is no significant difference between the wild 
type and the msaB deletion mutant, results of this study suggest that the eDNA is an 
important component to the composition of biofilm; however, it is not responsible for 
msaB mutant’s biofilm defect. 
 
Figure 17. Effect of DNaseI on biofilm formation in msaB mutant strain (Red bar), 
compared to the LAC wild type (Blue bar) and msaB complement (Green bar) strains. It 
shows decreased both wild and mutant strains after added DNase I (Test Group) 






































Addition of Proteinase K at any time point disrupted the biofilms in both wild and 
msaB mutant strains, so we can concluded that both the wild type (LAC) and msaB 
mutant strains were sensitive to DNaseI and proteinase K, and the protein and DNase I 
are important in biofilm structure (Figure 18). 
 
Figure 18. Effect of Proteinase K on biofilm formation in msaB mutant strain (Red bar), 
compared to the LAC wild type (Blue bar) and msaB complement (Green bar) strains. It 
shows decreased both wild and mutant strains after added proteinase k enzyme (Test 
Group) compared to control group (no proteinase K was added). 
 
Discussion 
For hundreds of years, scientists and dentists have been looking for efficient 
methods to control oral diseases, since the oral ecosystem view has become more widely 
accepted and oral bacterial interactions have been more elucidated [61]. Most infections 
of the oral cavity, including the major dental diseases, caries and periodontitis, are 
opportunistic in nature [62]. They are caused or maintained by microorganisms of the 
resident or transient flora normally present in low numbers and not pathogenic, but in 





















 Mucosal infections have some degree of specificity (e.g., Candida spp., 
Staphylococcus aureus, and enterics), and a microbiological test can be interpreted 
accurately for clinical diagnosis and choice of treatment. Sub-epithelial or deep infection 
include a number of species from the resident flora, mainly anaerobes whose role in the 
infections is difficult to interpret; however, microbiological tests for the presence of 
certain bacterial species could be used for treatment control, risk-evaluation, and even for 
patient motivation in the prevention of these diseases. Microbiological diagnosis can be 
used in general practice for several purposes and in various situations that can be of great 
value for the dental patient [63].  
The occurrence of staphylococci in the oral cavity was examined using saliva and 
supra-gingival plaque specimens from 56 systemically and periodentally healthy adults 
aged 22-43 years old. Nine staphylococcus species and 334 isolates were identified, and 
S. aureus was the most frequent species (46.4%), followed by staphylococcus 
epidermidis (41.1%) and other species [64].  
The ability of Staphylococcus spp and Candida spp to form a biofilm and live 
within certain niches allows them to develop mechanisms that increase persistence, such 
as the evasion of host defenses and antibiotic efficacy [12]. These microorganisms can 
easily be or become resistant to antibiotics and lead to super infection. While the 
diversity of organisms present in the oral cavity is well accepted, there remains 
considerable controversy as to whether Staphylococcus spp. play a role in the ecology of 
the normal oral flora [65].  
Surprisingly, little detailed work has been done on the qualitative and quantitative 




S. aureus [65]. The S. aureus is especially interesting in light of the present difficulty in 
eradicating carriers of methicillin-resistant S. aureus (MRSA) from the oropharynx of the 
affected individuals. Information on the risk of methicillin-resistant Staphylococcus 
aureus (MRSA) infection transmission in dental healthcare settings was incomplete only 
a few years ago; therefore, MRSA infection control guidelines were necessarily based on 
data extrapolated from other fields. Recently, publication of specific studies has made it 
possible to review such risk [66]. 
 In this study we studied the role of the msaB gene, which is a part of msaABCR 
operon that regulates biofilm development and other virulence factors in S. aureus. One 
of the interesting findings is the important role of msaB in biofilm formation in the S. 
aureus stains. Identification of the msaB will add insight into the complex network of 
virulence regulation in S. aureus.  
Despite the identification of numerous regulatory elements in S. aureus, it is still 
unclear how this organism achieves the coordinated expression of virulence factors in the 
host. It has been suggested that the unique regulation pattern of toxins and the biofilm 
formation in these strains are primarily responsible for their increased virulence and 
epidemic spread. Biofilm infections are extremely challenging to treat and the presence 
of biofilms causes numerous problems in the field of medicine, interfering with clinical 
therapeutics. 
The environmental factors, such as glucose, osmolarity, ethanol, temperature, and 
anaerobiosis, have been reported to affect biofilm formation [67]. Glucose has been 
shown to induce the multicellular aggregation step of biofilm formation [68]. Osmotic 




when grown under stress-induced conditions (NaCl, EthOH, sub-inhibitory levels of 
tetracycline). However, induction of biofilm by NaCl is dependent on the concentration 
of NaCl used [69]. Ethanol was shown to induce biofilm formation through icaR, which 
represses the icaADBC genes [70]. IcaR was recently shown to bind to the promoter 
region upstream of the icaA gene [71]. In contrast the effects of glucose and NaCl are not 
mediated through icaR [70, 72]. Depending on the strain, ethanol at various 
concentrations either positively or negatively regulates biofilm formation.  
One of the key phenotypes of the msaB mutant is the decreased formation of the 
biofilm formation. Indeed, there are several independent regulators and environmental 
stimuli which contribute to establish sessile communities of S. aureus [73], although the 
complete picture is still unclear and under investigation. COMSTAT analysis of confocal 
microscopy of the biofilm formation by the msaB deletion mutant showed the presence of 
significantly less live cell biomass by the mutant, 40% compared to 100% by the wild 
type. The complement produced the cell biomass intermediate between the wild type and 
complement. Moreover, the mutant showed the presence of increased cell death (169%) 
compared to wild type (100%). This analysis suggests that increased number of cell death 
might be responsible for the defective biofilm formation by the msaB mutant. Further 
analysis by the COMSTAT also revealed that the mutant has significantly reduced 
biofilm thickness (12 µm) compared to wild type (24 um).  
In this study we have shown that msaB acts as a regulator of several genes that are 
involved in protease production, virulence, and biofilm development. The msaB gene 
encodes a 66-amino acid polypeptide that showed homology with cold-shock proteins of 




aureus produces three proteins (CspA, CspB, and CspC) that may be associated with 
cold-shock stress [74, 75], however, Anderson et al., 2006 [76] showed that only CspB 
responds to cold shock in S. aureus. This was confirmed by proteomic studies that 
showed increased expression of CspB under cold shock, while CspA was not 
differentially expressed.  
Studies have also shown that the CspA transcript is more abundant than CspB and 
CspC under normal growth conditions at 37°C, while the CspB predominates at 15°C 
[76]. In addition, collective studies also have shown that the CspA is an important gene 
for the cationic antimicrobial peptide of human lysosomal cathepsin G, and regulates 
pigmentation in S. aureus through a sigB-dependent mechanism [74, 77]. This indicates 
that CspA has biological functions other than the cold-shock response. In E. coli, the 
CspA mRNA is a thermo sensor that modulates translation of the cold-shock protein 
(CspA). The CspA mRNA in E. coli undergoes post-transcriptional modification in 
response to environmental variations, such as a temperature shift from 37°C to 10°C [78, 
79]. This RNA-dependent regulation of gene expression allows E. coli to rapidly adapt 
and respond to its environment.  
Further studies have shown that the CspA gene in E. coli produces a single-
stranded nucleic acid-binding protein and an RNA chaperone. This protein is one of the 
most abundant proteins during early growth phase, and its expression is even higher 
during cold shock, accounting for 2% of the total proteins in the cell [80, 81]. Since msaB 
(CspA) is not directly involved in cold shock in S. aureus, it is not clear if it has 
maintained the same mechanism of regulation or functions as its homolog in E. coli. With 




complications such as antibiotics-resistance; therefore, understanding the virulence 
mechanisms of this microorganism is warranted to establish adequate diagnosis and 
provide proper treatment modalities.  
Furthermore, we examined different environmental conditions that effect biofilm 
formation on msaB mutant and compared them with msaB complement and the wild type 
USA300_LAC. We first examined the effects of osmotic stress (NaCl), which was found 
to induce biofilm formation in biofilm positive strains when grown under stress-induced 
conditions [58]. We found that in the presence of different NaCl concentrations there is 
no significant difference in the biofilm formation by the msaB mutant in any of the 
concentrations of NaCl tested compared to its wild type and complement (Figure 13). We 
also tested the effect of ethanol in combination with either NaCl or glucose in TSB. As 
shown in Figure 14, the biofilm produced by the msaB deletion mutant is not 
significantly different when grown in TSB/ethanol (Figure 14 A) and TSB/ethanol/NaCl 
(Figure 14 C); however, interestingly msaB deletion mutant produced significantly 
increased biofilm in TSB/ethanol/glucose (Figure 14 B). Further investigation is needed 
to understand why msaB mutant produces more biofilm in TSB/ethanol/glucose. 
Glucose has been shown to induce the multicellular aggregation step of biofilm 
formation, which increases PIA production [59], and thus induces biofilm formation. We 
found the defective biofilm formation by the msaB deletion mutant at low concentration 
of glucose, whereas, as the concentration of glucose increases above 1%, the mutant 
phenotype is restored in terms of biofilm formation back to wild type level. We still need 




whereas the wild type and complement does not respond much to the change in glucose 
concentration (Figure 15). 
Conclusion 
In conclusion, we defined the role of msaB gene, a part of a four-gene operon, 
msaABCR, that regulates virulence and biofilm development in S. aureus. We studied the 
role of msaB gene in regulating important global regulators of virulence genes like sarA 
and agr. We also studied its role in pathogenesis in terms of protease activity, autolysis, 
pigmentation, and biofilm formation. The msaB gene showed decreased pigmentation, 
increased protease activity, increased cell death, and reduced biofilm formation.  
These findings suggest that msaB is also an important gene in the msaABCR 
operon that regulates other global regulators and virulence in S. aureus. Further research 
is needed to address the mechanism of regulation of this operon and its interaction with 
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